Shenzhen S.E.
06:00:00 2024-04-23 pm EDT
5-day change
1st Jan Change
20.02
CNY
-0.60%
+0.60%
-12.84%
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Approves Final Cash Dividend for the Year 2019, Payable on June 1, 2020
May 22, 2020 at 03:38 pm EDT
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. approved final 2019 profit distribution plan of Cash dividend per 10 shares (tax included) CNY 1.00000000. The dividend will be payable on June 1, 2020. Record date is May 29, 2020 and ex-date is 01 June 2020.
Tranche Update on Wuhan Easy Diagnosis Biomedicine Co.,Ltd.'s Equity Buyback Plan announced on March 28, 2024.
Mar. 31
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. commences an Equity Buyback Plan for CNY 350 million worth of its shares, under the authorization approved on March 18, 2024.
Mar. 27
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. authorizes a Buyback Plan.
Feb. 29
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-30
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
23-08-30
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 06 June 2023
23-05-30
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Approves Dividend for 2022
23-05-15
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-04-26
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Proposes Profit Distribution for 2022
23-04-21
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-04-19
CI
China stocks retreat on concerns of surging COVID cases
22-12-12
RE
China stocks retreat on concerns of rising COVID cases
22-12-11
RE
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
22-10-26
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Announces Executive Elections
22-10-24
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.(XSEC:002932) added to S&P Global BMI Index
22-09-19
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Announces Interim Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 21 September 2022
22-09-14
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Approves Interim Cash Dividend for 2022
22-09-13
CI
Zhuhai Digifluidic Biotechnology Co., Ltd. announced that it has received CNY 100.596565 million in funding from Wuhan Easy Diagnosis Biomedicine Co.,Ltd., Guangzhou Funway Asset Management Co., Ltd., Guangzhou Huiju Xinxing Equity Investment Partnership
22-09-12
CI
Zhuhai Digifluidic Biotechnology Co. announced that it expects to receive CNY 0.747 million in funding from Wuhan Easy Diagnosis Biomedicine Co.,Ltd., Guangzhou Funway Asset Management Co., Ltd., Guangzhou Huiju Xinxing Equity Investment Partnership and another investor
22-09-08
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Announces the Profit Distribution Proposal for the First Half of 2022
22-08-25
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
22-07-29
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Implements Final Profit Distribution Plan for 2021, Payable on June 21, 2022
22-06-14
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Approves Cash Dividend for the Year 2021
22-05-23
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Proposes Final Dividend for the Year 2021
22-04-27
CI
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-04-25
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Wuhan Easy Diagnosis Biomedicine Co., Ltd. is a China-based company which is mainly engaged in research and development, manufacture and sales of Point of Care Testing (POCT) rapid diagnostic reagents and quick testing instruments. The Company's main products are POCT rapid diagnostic reagents, which can be divided into six categories: infectious diseases, cardiovascular and cerebrovascular diseases, kidney diseases, diabetes, gynecology and eugenics, and health checkups. The Company's main products are mainly used in domestic hospitals, health service centers, community clinics, medical examination centers and other medical institutions.
More about the company
1st Jan change
Capi.
-12.84% 646M -11.57% 7.4B +2.98% 5.47B +0.98% 4.51B +5.18% 4.42B -50.82% 3.29B +11.23% 2.66B -16.38% 2.07B -2.66% 1.68B -10.84% 1.66B
Diagnostic & Testing Substances
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
WUHAN EASY DIAGNOSIS BIOMEDICINE CO.,LTD. 
